Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections
- 16 January 2003
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 57 (1-2), 13-23
- https://doi.org/10.1016/s0166-3542(02)00196-1
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- 3-Deazaneplanocin A induces massively increased interferon-α production in Ebola virus-infected miceAntiviral Research, 2002
- Characterization of Wild-Type and Cidofovir-Resistant Strains of Camelpox, Cowpox, Monkeypox, and Vaccinia VirusesAntimicrobial Agents and Chemotherapy, 2002
- Cytomegalovirus treatment options in immunocompromised patientsExpert Opinion on Pharmacotherapy, 2001
- Clinical Pharmacokinetics of the Antiviral Nucleotide Analogues Cidofovir and AdefovirClinical Pharmacokinetics, 1999
- Adefovir DipivoxilDrugs, 1999
- Synthesis and Antiviral Evaluation of Analogs of Adenosine-N1-Oxide and 1-(Benzyloxy)AdenosineNucleosides and Nucleotides, 1998
- Potentiating effect of ribavirin on the anti-herpes activity of acyclovirAntiviral Research, 1991
- Inhibition of Vaccinia Virus Growth by the Nucleoside Analogue 1-beta-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, Ribavirin)Journal of General Virology, 1976
- Human and primate poxviruses: I. Growth characteristics of cytolytic and tumor variantsArchiv für die gesamte Virusforschung, 1975
- Dye Uptake Methods for Assessing Viral Cytopathogenicity and their Application to Interferon AssaysJournal of General Virology, 1969